Shattuck Labs, Inc. insider trading
Every open-market purchase and sale by Shattuck Labs, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Shattuck Labs, Inc.’s insiders pay?
From January 19, 2022 to June 11, 2026, 7 insiders reported 10 open-market purchases and 1 sale not made under a pre-set plan in Shattuck Labs, Inc. Twelve months after each purchase was reported, the shares were −48.0% against the S&P 500 on average (median −48.0%), over 1 purchase with a full year of prices; 0% beat the index. That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on January 20, 2022 into $4,915 by November 2, 2026, −13.9% a year. It held shares 21% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $10,732 (+1.5% a year), and held throughout $18,041 (+13.2%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Brous Tyler | Director | 2 | −48.0% (1) | 0% | 0 | — | July 1, 2024 |
| Golumbeski George | Director | 2 | — | — | 0 | — | April 27, 2022 |
| Green Jeremy | Director | 1 | — | — | 1 | — | December 6, 2024 |
| Schreiber Taylor | Chief Executive Officer | 2 | — | — | 0 | — | October 8, 2024 |
| Ashiya Mona | Director | 1 | — | — | 0 | — | September 2, 2025 |
| Orbimed Capital Gp Ix LLC | Director | 1 | — | — | 0 | — | September 2, 2025 |
| Siegall Clay B | Director | 1 | — | — | 0 | — | June 11, 2026 |